Nutrien Statistics
Total Valuation
Nutrien has a market cap or net worth of $27.66 billion. The enterprise value is $39.76 billion.
| Market Cap | 27.66B |
| Enterprise Value | 39.76B |
Important Dates
The next estimated earnings date is Wednesday, November 5, 2025, after market close.
| Earnings Date | Nov 5, 2025 |
| Ex-Dividend Date | Sep 29, 2025 |
Share Statistics
Nutrien has 485.88 million shares outstanding. The number of shares has decreased by -0.74% in one year.
| Current Share Class | 485.88M |
| Shares Outstanding | 485.88M |
| Shares Change (YoY) | -0.74% |
| Shares Change (QoQ) | -0.40% |
| Owned by Insiders (%) | n/a |
| Owned by Institutions (%) | n/a |
| Float | 485.42M |
Valuation Ratios
The trailing PE ratio is 20.38 and the forward PE ratio is 11.45.
| PE Ratio | 20.38 |
| Forward PE | 11.45 |
| PS Ratio | 1.11 |
| Forward PS | 1.04 |
| PB Ratio | 1.10 |
| P/TBV Ratio | 2.46 |
| P/FCF Ratio | 15.28 |
| P/OCF Ratio | 7.53 |
| PEG Ratio | n/a |
Enterprise Valuation
The stock's EV/EBITDA ratio is 8.61, with an EV/FCF ratio of 21.97.
| EV / Earnings | 29.17 |
| EV / Sales | 1.59 |
| EV / EBITDA | 8.61 |
| EV / EBIT | 14.92 |
| EV / FCF | 21.97 |
Financial Position
The company has a current ratio of 1.33, with a Debt / Equity ratio of 0.54.
| Current Ratio | 1.33 |
| Quick Ratio | 0.80 |
| Debt / Equity | 0.54 |
| Debt / EBITDA | 2.71 |
| Debt / FCF | 7.53 |
| Interest Coverage | 3.94 |
Financial Efficiency
Return on equity (ROE) is 5.53% and return on invested capital (ROIC) is 4.31%.
| Return on Equity (ROE) | 5.53% |
| Return on Assets (ROA) | 3.14% |
| Return on Invested Capital (ROIC) | 4.31% |
| Return on Capital Employed (ROCE) | 6.42% |
| Revenue Per Employee | $1.01M |
| Profits Per Employee | $55,182 |
| Employee Count | 24,700 |
| Asset Turnover | 0.47 |
| Inventory Turnover | 3.21 |
Taxes
In the past 12 months, Nutrien has paid $497.00 million in taxes.
| Income Tax | 497.00M |
| Effective Tax Rate | 26.32% |
Stock Price Statistics
The stock price has increased by +20.08% in the last 52 weeks. The beta is 1.20, so Nutrien's price volatility has been higher than the market average.
| Beta (5Y) | 1.20 |
| 52-Week Price Change | +20.08% |
| 50-Day Moving Average | 58.61 |
| 200-Day Moving Average | 53.83 |
| Relative Strength Index (RSI) | 39.75 |
| Average Volume (20 Days) | 2,109,327 |
Short Selling Information
The latest short interest is 3.43 million, so 0.71% of the outstanding shares have been sold short.
| Short Interest | 3.43M |
| Short Previous Month | 6.22M |
| Short % of Shares Out | 0.71% |
| Short % of Float | 0.71% |
| Short Ratio (days to cover) | 1.70 |
Income Statement
In the last 12 months, Nutrien had revenue of $25.02 billion and earned $1.36 billion in profits. Earnings per share was $2.77.
| Revenue | 25.02B |
| Gross Profit | 7.58B |
| Operating Income | 2.67B |
| Pretax Income | n/a |
| Net Income | 1.36B |
| EBITDA | 4.62B |
| EBIT | 2.67B |
| Earnings Per Share (EPS) | $2.77 |
Balance Sheet
The company has $1.39 billion in cash and $13.64 billion in debt, giving a net cash position of -$12.25 billion or -$25.21 per share.
| Cash & Cash Equivalents | 1.39B |
| Total Debt | 13.64B |
| Net Cash | -12.25B |
| Net Cash Per Share | -$25.21 |
| Equity (Book Value) | 25.12B |
| Book Value Per Share | 51.53 |
| Working Capital | 3.84B |
Cash Flow
In the last 12 months, operating cash flow was $3.67 billion and capital expenditures -$1.86 billion, giving a free cash flow of $1.81 billion.
| Operating Cash Flow | 3.67B |
| Capital Expenditures | -1.86B |
| Free Cash Flow | 1.81B |
| FCF Per Share | $3.73 |
Margins
Gross margin is 30.28%, with operating and profit margins of 10.65% and 5.45%.
| Gross Margin | 30.28% |
| Operating Margin | 10.65% |
| Pretax Margin | 7.55% |
| Profit Margin | 5.45% |
| EBITDA Margin | 18.46% |
| EBIT Margin | 10.65% |
| FCF Margin | 7.23% |
Dividends & Yields
This stock pays an annual dividend of $2.18, which amounts to a dividend yield of 3.86%.
| Dividend Per Share | $2.18 |
| Dividend Yield | 3.86% |
| Dividend Growth (YoY) | 1.16% |
| Years of Dividend Growth | 7 |
| Payout Ratio | 78.61% |
| Buyback Yield | 0.74% |
| Shareholder Yield | 4.58% |
| Earnings Yield | 4.93% |
| FCF Yield | 6.54% |
Analyst Forecast
The average price target for Nutrien is $61.53, which is 9.19% higher than the current price. The consensus rating is "Hold".
| Price Target | $61.53 |
| Price Target Difference | 9.19% |
| Analyst Consensus | Hold |
| Analyst Count | 17 |
| Revenue Growth Forecast (5Y) | 1.36% |
| EPS Growth Forecast (5Y) | 23.83% |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | |
| Lynch Upside | |
| Graham Number | |
| Graham Upside |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
Nutrien has an Altman Z-Score of 1.56 and a Piotroski F-Score of 5. A Z-score under 3 suggests an increased risk of bankruptcy.
| Altman Z-Score | 1.56 |
| Piotroski F-Score | 5 |